Cell and Tissue Research

, Volume 351, Issue 3, pp 373–382 | Cite as

Distribution of microglia in the postnatal murine nigrostriatal system

  • Ahmed Sharaf
  • Kerstin Krieglstein
  • Björn SpittauEmail author
Regular Article


Parkinson’s disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra (SN) and the subsequent loss of striatal target innervation. Neuroinflammatory responses have been described for virtually all PD cases analysed. Microglia are the resident immune cells of the central nervous system and, thus, are the mediators of neuroinflammation. Approximately 12% of all central nervous system cells are microglia but the distribution and density of microglia differ within distinct brain regions. Interestingly, the SN has been shown to contain more microglia than adjacent structures. We have analysed changes in microglia numbers and in microglial morphology in the postnatal murine nigrostriatal system at various stages ranging from postnatal day 0 (P0) up to 24 months of age. We clearly show that the microglia numbers in the SN and in the striatum dramatically increase from P0 to P15 and significantly decrease in both areas in 18-month-old and 24-month-old animals. Moreover, microglia in the nigrostriatal system of aged mice show signs of dystrophy and degeneration, such as cytoplasmic inclusions, deramification of their processes and membrane blebbing. Our results support the hypothesis of microglial dystrophy during aging in the murine nigrostriatal system, accompanied by subsequent impairment of normal microglial functions. Microglial dysfunction during aging might be a potential risk factor for the development and/or progression of PD.


Microglia Midbrain Substantia nigra Striatum Aging Parkinson’s disease Mouse 



The authors thank the Ministry of Higher Education and State of Scientific Research in Egypt.


  1. Adams JC (1981) Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29:775PubMedCrossRefGoogle Scholar
  2. Conde JR, Streit WJ (2006) Microglia in the aging brain. J Neuropathol Exp Neurol 65:199–203PubMedGoogle Scholar
  3. Fotheringham AP, Davies CA, Davies I (2000) Oedema and glial cell involvement in the aged mouse brain after permanent focal ischaemia. Neuropathol Appl Neurobiol 26:412–423PubMedCrossRefGoogle Scholar
  4. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San DiegoGoogle Scholar
  5. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841–845PubMedCrossRefGoogle Scholar
  6. Graeber MB, Streit WJ (2010) Microglia: biology and pathology. Acta Neuropathol 119:89–105PubMedCrossRefGoogle Scholar
  7. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol 8:382–397PubMedCrossRefGoogle Scholar
  8. Hua JY, Smith SJ (2004) Neural activity and the dynamics of central nervous system development. Nat Neurosci 7:327–332PubMedCrossRefGoogle Scholar
  9. Huberman AD, Feller MB, Chapman B (2008) Mechanisms underlying development of visual maps and receptive fields. Annu Rev Neurosci 31:479–509PubMedCrossRefGoogle Scholar
  10. Jellinger KA (2001) The pathology of Parkinson’s disease. Adv Neurol 86:55–72PubMedGoogle Scholar
  11. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20:6309–6316PubMedGoogle Scholar
  12. Kurz H, Christ B (1998) Embryonic CNS macrophages and microglia do not stem from circulating, but from extravascular precursors. Glia 22:98–102PubMedCrossRefGoogle Scholar
  13. Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151–170PubMedCrossRefGoogle Scholar
  14. Lee CYD, Landreth GE (2010) The role of microglia in amyloid clearance from the AD brain. J Neural Transm 117:949–960PubMedCrossRefGoogle Scholar
  15. Oberle S, Schober A, Meyer V, Holtmann B, Henderson C, Sendtner M, Unsicker K(2006) Loss of leukemia inhibitory factor receptor beta or cardiotrophin-1 causes similar deficits in preganglionic sympathetic neurons and adrenal medulla. J Neurosci 26:1823–1832PubMedCrossRefGoogle Scholar
  16. Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M (2006) Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice. Neurosci Lett 401:183–187PubMedCrossRefGoogle Scholar
  17. Peinado MA, Quesada A, Pedrosa JA, Torres MI, Martinez M, Esteban FJ, Del Moral ML, Hernandez R, Rodrigo J, Peinado JM (1998) Quantitative and ultrastructural changes in glia and pericytes in the parietal cortex of the aging rat. Microsc Res Tech 43:34–42PubMedCrossRefGoogle Scholar
  18. Peters A, Josephson K, Vincent SL (1991) Effects of aging on the neuroglial cells and pericytes within area 17 of the rhesus monkey cerebral cortex. Anat Rec 229:384–398PubMedCrossRefGoogle Scholar
  19. Prinz M, Mildner A (2011) Microglia in the CNS: immigrants from another world. Glia 59:177–187PubMedCrossRefGoogle Scholar
  20. Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A (2007) Neuroinflammation in Alzheimer’s disease and Parkinson’s disease: are microglia pathogenic in either disorder? Int Rev Neurobiol 82:235–246PubMedCrossRefGoogle Scholar
  21. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B (2012) Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74:691–705PubMedCrossRefGoogle Scholar
  22. Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson’s disease. Mov Disord 26:1049–1055PubMedCrossRefGoogle Scholar
  23. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ, Geissmann F (2012) A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336:86–90PubMedCrossRefGoogle Scholar
  24. Smidt MP, Burbach JPH (2007) How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci 8:21–32PubMedCrossRefGoogle Scholar
  25. Streit WJ (2006) Microglial senescence: does the brain’s immune system have an expiration date? Trends Neurosci 29:506–510PubMedCrossRefGoogle Scholar
  26. Streit WJ, Sammons NW, Kuhns AJ, Sparks DL (2004) Dystrophic microglia in the aging human brain. Glia 45:208–212PubMedCrossRefGoogle Scholar
  27. Streit WJ, Braak H, Xue Q-S, Bechmann I (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol 118:475–485PubMedCrossRefGoogle Scholar
  28. Tremblay MÈ, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A (2011) The role of microglia in the healthy brain. J Neurosci 31:16064–16069Google Scholar
  29. Van den Heuvel DMA, Pasterkamp RJ (2008) Getting connected in the dopamine system. Prog Neurobiol 85:75–93PubMedCrossRefGoogle Scholar
  30. Vaughan DW, Peters A (1974) Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: an electron microscope study. J Neurocytol 3:405–429PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Ahmed Sharaf
    • 1
    • 3
  • Kerstin Krieglstein
    • 1
    • 2
  • Björn Spittau
    • 1
    Email author
  1. 1.Institute of Anatomy & Cell Biology, Department of Molecular EmbryologyAlbert-Ludwigs-University FreiburgFreiburgGermany
  2. 2.Freiburg Institute for Advanced Studies (FRIAS)Albert-Ludwigs-University FreiburgFreiburgGermany
  3. 3.Faculty of BiologyAlbert-Ludwigs-University FreiburgFreiburgGermany

Personalised recommendations